Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomized, Double-Blind, Placebo-Controlled Study of Diazoxide Choline Controlled-Release Tablet (DCCR) in Patients With Prader-Willi Syndrome

Trial Profile

A Randomized, Double-Blind, Placebo-Controlled Study of Diazoxide Choline Controlled-Release Tablet (DCCR) in Patients With Prader-Willi Syndrome

Status: Recruiting
Phase of Trial: Phase III

Latest Information Update: 10 Oct 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Diazoxide (Primary)
  • Indications Prader-Willi syndrome
  • Focus Registrational; Therapeutic Use
  • Acronyms DESTINY PWS
  • Sponsors Soleno Therapeutics
  • Most Recent Events

    • 02 Oct 2019 According to a Soleno Therapeutics media release, Data Safety Monitoring Board (DSMB) has, for the second time, recommended the continuation of this trial without modification The outcome of this second planned meeting was based on the review of data from more than 50% of patients enrolled and treated.
    • 25 Jul 2019 Results presented in the Soleno Therapeutics media release.
    • 25 Jul 2019 According to a Soleno Therapeutics media release, approximately 50% of the targeted number of patients have been enrolled in this trial as of July 24, 2019 and more than 90% of those patients have either successfully completed or continue to be treated on study. Over 90% of subjects who have completed the study have elected to continue in 9-month open-label safety extension study (C602).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top